<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36496499</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The utility of telemedicine in managing patients after COVID-19.</ArticleTitle><Pagination><StartPage>21392</StartPage><MedlinePgn>21392</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21392</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-25348-2</ELocationID><Abstract><AbstractText>Despite growing knowledge about transmission and relatively wide access to prophylaxis, the world is still facing a severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) global pandemic. Under these circumstances telemedicine emerges as a powerful tool for safe at-home surveillance after a hospital discharge; the data on when to safely release a patient after acute COVID-19 is scarce. Reckoning an urgent need for improving outpatient management and possibly fatal complications of the post-COVID period, we performed the pilot telemonitoring program described below. The study aimed to assess the usefulness of parameters and surveys remotely obtained from COVID-19 convalescents in their individual prognosis prediction. Patients were involved in the study between December 2020 and May 2021. Recruitment was performed either during the hospital discharge (those hospitalized in a Barlicki Memorial Hospital in Lodz) or the first outpatient visit up to 6&#xa0;weeks after discharge from another center. Every participant received equipment for daily saturation and heart rate measurement coupled with a tablet for remote data transmission. The measurements were made after at least fifteen minutes of rest in a sitting position without oxygen supplementation. Along with the measurements, the cough and dyspnea daily surveys (1-5 points) and Fatigue Assessment Scale weekly surveys were filled. We expected a saturation decrease during thromboembolic events, infectious complications, etc. A total of 30 patients were monitored for a minimum period of 45&#xa0;days, at least 2&#xa0;weeks after spontaneous saturation normalization. The mean age was 55 (mean 55.23; SD&#x2009;&#xb1;&#x2009;10.64&#xa0;years). The group was divided according to clinical improvement defined as the &#x2265;&#x2009;10% functional vital capacity (FVC) raise or &#x2265;&#x2009;15% lung transfer for carbon monoxide (T<sub>L,CO</sub>) rise. Our findings suggest that at-rest home saturation measurements below 94% (p&#x2009;=&#x2009;0.03) correspond with the lack of clinical improvement in post-COVID observation (p&#x2009;=&#x2009;0.03). The non-improvement group presented with a lower mean-94 (93-96)% versus 96 (95-97)%, p&#x2009;=&#x2009;0.01 and minimum saturation-89 (86-92)% versus 92 (90-94)%, p&#x2009;=&#x2009;0.04. They also presented higher variations in saturation measurements; saturation amplitude was 9 (7-11)% versus 7 (4-8)%, p&#x2009;=&#x2009;0.03; up to day 22 most of the saturation differences reached statistical significance. Last but not least, we discovered that participants missing 2 or more measurements during the observation were more often ranked into the clinical improvement group (p&#x2009;=&#x2009;0.01). Heart rate day-to-day measurements did not differ between both groups; gathered data about dyspnea and cough intensity did not reach statistical significance either. A better understanding of the disease's natural history will ultimately lead us to a better understanding of long COVID symptoms and corresponding threats. In this paper, we have found home oxygen saturation telemonitoring to be useful in the prediction of the trajectory of the disease course. Our findings suggest that detection of at-rest home saturation measurement equal to or below 94% corresponds with the lack of clinical improvement at the time of observation and this group of patients presented higher variability of day-to-day oxygen saturation measurements. The determination of which patient should be involved in telemedicine programs after discharge requests further research.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bartczak</LastName><ForeName>Krystian T</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland. krystian.bartczak@umed.lodz.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milkowska-Dymanowska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piotrowski</LastName><ForeName>Wojciech J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bialas</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Medical University of Lodz, Kopcinskiego 22, 90-153, Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Rehabilitation, Center for Lung Diseases and Rehabilitation, Blessed Rafal Chylinski Memorial Hospital for Lung Diseases, Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>10</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36496499</ArticleId><ArticleId IdType="pmc">PMC9736706</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-25348-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-25348-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID-19. J. Allergy Clin. Immunol. Pract. 2020;8:1489&#x2013;1491. doi: 10.1016/j.jaip.2020.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2020.03.008</ArticleId><ArticleId IdType="pmc">PMC7104202</ArticleId><ArticleId IdType="pubmed">32220575</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite VF, Rampim DB, Jorge VC, de Lima MCC, Cezarino LG, da Rocha CN, et al. Persistent symptoms and disability after COVID-19 hospitalization: Data from a comprehensive telerehabilitation program. Arch. Phys. Med. Rehabil. 2021;102:1308&#x2013;1316. doi: 10.1016/j.apmr.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7943375</ArticleId><ArticleId IdType="pubmed">33711279</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi M, Leelaviwat N, Eshak N, Mekraksakit P, Nugent K, Payne JD. COVID-19 discharge and follow-up recommendations. Proc. Bayl. Univ. Med. Cent. 2020;34:73&#x2013;75. doi: 10.1080/08998280.2020.1834341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2020.1834341</ArticleId><ArticleId IdType="pmc">PMC7785155</ArticleId><ArticleId IdType="pubmed">33456149</ArticleId></ArticleIdList></Reference><Reference><Citation>Telemedicine I of M (US) C on ECA of, Field MJ. Introduction and background [Internet]. Telemed. Guide Assess. Telecommun. Health Care. National Academies Press (US); 1996 [cited 2021 Nov 1]. https://www.ncbi.nlm.nih.gov/books/NBK45440/.</Citation></Reference><Reference><Citation>Keshvardoost S, Bahaadinbeigy K, Fatehi F. Role of telehealth in the management of COVID-19: Lessons learned from previous SARS, MERS, and ebola outbreaks. Telemed. J. E-Health Off. J. Am. Telemed. Assoc. 2020;26:850&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329659</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries R, Kriebel D, Sama S. Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation. NPJ Prim. Care Respir. Med. 2016;26:1&#x2013;3. doi: 10.1038/npjpcrm.2016.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjpcrm.2016.83</ArticleId><ArticleId IdType="pmc">PMC5131613</ArticleId><ArticleId IdType="pubmed">27906157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisman EZ, Shapira I, Motro M, Pines A, Tenenbaum A. The combined cough frequency/severity scoring: A new approach to cough evaluation in clinical settings. J. Med. 2001;32:181&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">11563816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuyts WA, Wijsenbeek M, Bondue B, Bouros D, Bresser P, Robalo Cordeiro C, et al. Idiopathic pulmonary fibrosis: Best practice in monitoring and managing a relentless fibrotic disease. Respiration. 2020;99:73&#x2013;82. doi: 10.1159/000504763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000504763</ArticleId><ArticleId IdType="pmc">PMC6979429</ArticleId><ArticleId IdType="pubmed">31830755</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterniti MO, Bi Y, Reki&#x107; D, Wang Y, Karimi-Shah BA, Chowdhury BA. Acute exacerbation and decline in forced vital capacity are associated with increased mortality in idiopathic pulmonary fibrosis. Ann. Am. Thorac. Soc. 2017;14:1395&#x2013;402. doi: 10.1513/AnnalsATS.201606-458OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201606-458OC</ArticleId><ArticleId IdType="pubmed">28388260</ArticleId></ArticleIdList></Reference><Reference><Citation>Doubkov&#xe1; M, &#x160;vancara J, Svoboda M, &#x160;terclov&#xe1; M, Barto&#x161; V, Pla&#x10d;kov&#xe1; M, et al. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis. Clin. Respir. J. 2018;12:1526&#x2013;1535. doi: 10.1111/crj.12700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.12700</ArticleId><ArticleId IdType="pubmed">28862397</ArticleId></ArticleIdList></Reference><Reference><Citation>Launay D, Buchdahl A-L, Berezn&#xe9; A, Hatron P-Y, Hachulla E, Mouthon L. Mycophenolate mofetil following cyclophosphamide in worsening systemic sclerosis-associated interstitial lung disease. J. Scleroderma Relat. Disord. 2016;1:234&#x2013;240. doi: 10.5301/jsrd.5000205.</Citation><ArticleIdList><ArticleId IdType="doi">10.5301/jsrd.5000205</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh NS, Hoyles RK, Denton CP, Hansell DM, Renzoni EA, Maher TM, et al. Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69:1670&#x2013;1678. doi: 10.1002/art.40130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40130</ArticleId><ArticleId IdType="pubmed">28426895</ArticleId></ArticleIdList></Reference><Reference><Citation>Reducing Ebola Virus Transmission: Improving Contact Tracing in Sierra Leone [Internet]. Innov. Poverty Action. 2015 [cited 2021 Dec 10]. https://www.poverty-action.org/study/reducing-ebola-virus-transmission-improving-contact-tracing-sierra-leone</Citation></Reference><Reference><Citation>Chang, T., Lee, J. &amp; Wu, S. The telemedicine and teleconsultation system application in clinical medicine. In Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 3392&#x2013;3395 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">17271012</ArticleId></ArticleIdList></Reference><Reference><Citation>Blozik E, Grandchamp C, von Overbeck J. Influenza surveillance using data from a telemedicine centre. Int. J. Public Health. 2012;57:447&#x2013;452. doi: 10.1007/s00038-011-0240-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-011-0240-1</ArticleId><ArticleId IdType="pubmed">21318326</ArticleId></ArticleIdList></Reference><Reference><Citation>Omboni S. Telemedicine during the COVID-19 in Italy: A missed opportunity? Telemed. J. E-Health Off. J. Am. Telemed. Assoc. 2020;26:973&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7415870</ArticleId><ArticleId IdType="pubmed">32324109</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: A call to action. JMIR Public Health Surveill. 2020;6:e18810. doi: 10.2196/18810.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18810</ArticleId><ArticleId IdType="pmc">PMC7124951</ArticleId><ArticleId IdType="pubmed">32238336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai, Y., et al. From isolation to coordination: How can telemedicine help combat the COVID-19 outbreak? [Internet]. 2020, p. 2020.02.20.20025957. 10.1101/2020.02.20.20025957v1.</Citation></Reference><Reference><Citation>Yordanov Y, Dechartres A, Lescure X, Apra C, Villie P, Marchand-Arvier J, et al. Covidom, a telesurveillance solution for home monitoring patients with COVID-19. J. Med. Internet Res. 2020;22:e20748. doi: 10.2196/20748.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20748</ArticleId><ArticleId IdType="pmc">PMC7644373</ArticleId><ArticleId IdType="pubmed">33006938</ArticleId></ArticleIdList></Reference><Reference><Citation>Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan B-A, et al. Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): A randomised, controlled, parallel-group, unmasked trial. The Lancet. 2018;392:1047&#x2013;1057. doi: 10.1016/S0140-6736(18)31880-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)31880-4</ArticleId><ArticleId IdType="pubmed">30153985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi&#x142;kowska-Dymanowska J, Bia&#x142;as AJ, Obr&#x119;bski W, G&#xf3;rski P, Piotrowski WJ. A pilot study of daily telemonitoring to predict acute exacerbation in chronic obstructive pulmonary disease. Int. J. Med. Inf. 2018;116:46&#x2013;51. doi: 10.1016/j.ijmedinf.2018.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2018.04.013</ArticleId><ArticleId IdType="pubmed">29887234</ArticleId></ArticleIdList></Reference><Reference><Citation>Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Chavannes NH, et al. Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial. Am. J. Respir. Crit. Care Med. 2020;202:393&#x2013;401. doi: 10.1164/rccm.202002-0328OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202002-0328OC</ArticleId><ArticleId IdType="pubmed">32325005</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta LP, da Silva PPF, Borguezan BM, do Amaral JLM, Milagres LG, B&#xf3;ia MN, et al. An emergency system for monitoring pulse oximetry, peak expiratory flow, and body temperature of patients with COVID-19 at home: Development and preliminary application. PLoS ONE. 2021;16:e0247635. doi: 10.1371/journal.pone.0247635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247635</ArticleId><ArticleId IdType="pmc">PMC7996990</ArticleId><ArticleId IdType="pubmed">33770093</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Carroll O, MacCann R, O&#x2019;Reilly A, Dunican EM, Feeney ER, Ryan S, et al. Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia. Eur. Respir. J. 2020;56:2001492. doi: 10.1183/13993003.01492-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01492-2020</ArticleId><ArticleId IdType="pmc">PMC7331654</ArticleId><ArticleId IdType="pubmed">32616588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Garc&#xed;a M, Bal-Alvarado M, Santos Guerra F, Ares-Rico R, Su&#xe1;rez-Gil R, Rodr&#xed;guez-&#xc1;lvarez A, et al. Monitoring of COVID-19 patients via telemedicine with telemonitoring. Rev. Clin. Esp. 2020;220:472&#x2013;479. doi: 10.1016/j.rce.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274600</ArticleId><ArticleId IdType="pubmed">33994572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders C, Rogers A, Bowen R, Bower P, Hirani S, Cartwright M, et al. Exploring barriers to participation and adoption of telehealth and telecare within the whole system demonstrator trial: A qualitative study. BMC Health Serv. Res. 2012;12:220. doi: 10.1186/1472-6963-12-220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-12-220</ArticleId><ArticleId IdType="pmc">PMC3413558</ArticleId><ArticleId IdType="pubmed">22834978</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang C, Voigt K, Neumann R, Bergmann A, Holthoff-Detto V. Adherence and acceptance of a home-based telemonitoring application used by multi-morbid patients aged 65 years and older. J. Telemed. Telecare. 2020;28:37&#x2013;51. doi: 10.1177/1357633X20901400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633X20901400</ArticleId><ArticleId IdType="pmc">PMC8721554</ArticleId><ArticleId IdType="pubmed">32009577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook EJ, Randhawa G, Sharp C, Ali N, Guppy A, Barton G, et al. Exploring the factors that influence the decision to adopt and engage with an integrated assistive telehealth and telecare service in Cambridgeshire, UK: A nested qualitative study of patient &#x2018;users&#x2019; and &#x2018;non-users&#x2019;. BMC Health Serv. Res. 2016;16:137. doi: 10.1186/s12913-016-1379-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-016-1379-5</ArticleId><ArticleId IdType="pmc">PMC4837551</ArticleId><ArticleId IdType="pubmed">27095102</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster A, Horspool KA, Edwards L, Thomas CL, Salisbury C, Montgomery AA, et al. Who does not participate in telehealth trials and why? A cross-sectional survey. Trials. 2015;16:258. doi: 10.1186/s13063-015-0773-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-015-0773-3</ArticleId><ArticleId IdType="pmc">PMC4464859</ArticleId><ArticleId IdType="pubmed">26044763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P, Wang Z, Guo X, Feng Z, Chen C, Zheng A, et al. Pulmonary rehabilitation accelerates the recovery of pulmonary function in patients with COVID-19. Front. Cardiovasc. Med. 2021;8:691609. doi: 10.3389/fcvm.2021.691609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.691609</ArticleId><ArticleId IdType="pmc">PMC8329030</ArticleId><ArticleId IdType="pubmed">34355029</ArticleId></ArticleIdList></Reference><Reference><Citation>Munker D, Veit T, Barton J, Mertsch P, M&#xfc;mmler C, Osterman A, et al. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 2021;50:157&#x2013;168. doi: 10.1007/s15010-021-01669-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01669-8</ArticleId><ArticleId IdType="pmc">PMC8318328</ArticleId><ArticleId IdType="pubmed">34322859</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>